{"id":2190,"date":"2024-08-30T21:56:32","date_gmt":"2024-08-30T19:56:32","guid":{"rendered":"https:\/\/studienportal-eierstockkrebs.de\/tin-tuc-tu-khoa-hoc-va-thuc-tien\/"},"modified":"2026-02-13T13:23:01","modified_gmt":"2026-02-13T12:23:01","slug":"tin-tuc-tu-khoa-hoc-va-thuc-tien","status":"publish","type":"page","link":"https:\/\/studienportal-eierstockkrebs.de\/vi\/tin-tuc-tu-khoa-hoc-va-thuc-tien\/","title":{"rendered":"Tin t\u1ee9c t\u1eeb khoa h\u1ecdc v\u00e0 th\u1ef1c ti\u1ec5n"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Tin t\u1ee9c<\/strong>
Tin t\u1ee9c t\u1eeb khoa h\u1ecdc v\u00e0 th\u1ef1c ti\u1ec5n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n
\n
<\/i><\/a><\/div>
\n \"\"\n <\/div>\n <\/div>

\u0110i\u1ec3m n\u1ed5i b\u1eadt t\u1eeb ESGO 2026 v\u00e0 s\u1ef1 ph\u00ea duy\u1ec7t m\u1edbi!<\/a><\/h3><\/header>
\n

Ch\u00fang t\u00f4i \u0111\u00e3 tham d\u1ef1 h\u1ed9i ngh\u1ecb ESGO \u1edf Copenhagen v\u00e0 xem b\u00e0i thuy\u1ebft tr\u00ecnh v\u1ec1 k\u1ebft qu\u1ea3 nghi\u00ean c\u1ee9u, v\u1ed1n \u0111\u00e3 \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t v\u00e0o th\u00e1ng Hai! Ph\u1ed1i...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

D\u1eef li\u1ec7u cu\u1ed1i c\u00f9ng m\u1edbi: Li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch v\u1edbi atezolizumab kh\u00f4ng mang l\u1ea1i l\u1ee3i \u00edch b\u1ed5 sung n\u00e0o trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0 bu\u1ed3ng tr\u1ee9ng t\u00e1i ph\u00e1t.<\/a><\/h3><\/header>
\n

D\u1eef li\u1ec7u cu\u1ed1i c\u00f9ng m\u1edbi: Li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch v\u1edbi atezolizumab kh\u00f4ng mang l\u1ea1i l\u1ee3i \u00edch b\u1ed5 sung n\u00e0o trong \u0111i\u1ec1u tr\u1ecb ung th\u01b0 bu\u1ed3ng tr\u1ee9ng t\u00e1i ph\u00e1t. K\u1ebft qu\u1ea3...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

AGO-OVAR 27- WoO<\/a><\/h3><\/header>
\n

AGO-OVAR 27 – WoO WoO: Nghi\u00ean c\u1ee9u v\u1ec1 c\u01a1 h\u1ed9i \u0111i\u1ec1u tr\u1ecb b\u1eb1ng Olaparib v\u00e0 Durvalumab trong ung th\u01b0 bu\u1ed3ng tr\u1ee9ng \u0111\u00e3 \u0111\u01b0\u1ee3c x\u00e1c nh\u1eadn b\u1eb1ng m\u00f4 h\u1ecdc. Nh\u00f3m A...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n
<\/i><\/a><\/div>
\n \"\"\n <\/div>\n <\/div>

M\u1ee5c ti\u00eau nghi\u00ean c\u1ee9u \u0111\u00e3 \u0111\u1ea1t \u0111\u01b0\u1ee3c! \u2013 K\u1ebft qu\u1ea3 nghi\u00ean c\u1ee9u ROSELLA<\/a><\/h3><\/header>
\n

Nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi v\u1ec1 \u0111i\u1ec1u tr\u1ecb ung th\u01b0 bu\u1ed3ng tr\u1ee9ng kh\u00e1ng platinum \u2013 k\u1ebft qu\u1ea3 c\u1ee7a nghi\u00ean c\u1ee9u ROSELLA V\u00e0o cu\u1ed1i th\u00e1ng Gi\u00eang, c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m Corcept Therapeutics...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n
<\/i><\/a><\/div>
\n \"\"\n <\/div>\n <\/div>

Tin t\u1ee9c d\u00e0nh cho b\u1ec7nh nh\u00e2n ung th\u01b0 bu\u1ed3ng tr\u1ee9ng kh\u00e1ng platinum<\/a><\/h3><\/header>
\n

Tin t\u1ee9c d\u00e0nh cho b\u1ec7nh nh\u00e2n m\u1eafc ung th\u01b0 bu\u1ed3ng tr\u1ee9ng kh\u00e1ng platinum C\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m Eli Lilly g\u1ea7n \u0111\u00e2y \u0111\u00e3 nh\u1eadn \u0111\u01b0\u1ee3c Ch\u1ee9ng nh\u1eadn Li\u1ec7u ph\u00e1p \u0110\u1ed9t ph\u00e1...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

NIS Niraparib \u2013 NOGGO-ov45 \u2013 CAROLIN<\/a><\/h3><\/header>
\n

NIS Niraparib \u2013 NOGGO-ov45 \u2013 CAROLIN D\u00e0nh cho b\u1ec7nh nh\u00e2n ung th\u01b0 bu\u1ed3ng tr\u1ee9ng nh\u1ea1y c\u1ea3m v\u1edbi platin kh\u00f4ng c\u00f3 ch\u1ed1ng ch\u1ec9 \u0111\u1ecbnh v\u1edbi niraparib. Nghi\u00ean c\u1ee9u quan s\u00e1t kh\u00f4ng...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

Bi\u1ec3u th\u1ee9c XVIII (18)<\/a><\/h3><\/header>
\n

NOGGO S30\/ Bi\u1ec3u th\u1ee9c XVIII (18) KH\u1ea2O S\u00c1T QU\u1ed0C T\u1ebe V\u1ec0 T\u00c1C \u0110\u1ed8NG C\u1ee6A KH\u1ee6NG HO\u1ea2NG \u0110\u1ed0I V\u1edaI B\u1ec6NH NH\u00c2N N\u1eee M\u1eaeC B\u1ec6NH UNG TH\u01af PH\u1ee4 KHOA Lo l\u1eafng l\u00e0...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

BI\u1ec2U TH\u1ee8C IX (9)<\/a><\/h3><\/header>
\n

NOGGO S20 \/ ENGOTgyn4 \u2013 BI\u1ec2U HI\u1ec6N IX (9) S\u1ed1ng s\u00f3t l\u00e2u d\u00e0i v\u1edbi ung th\u01b0 ph\u1ee5 khoa \/ Nh\u1eefng ng\u01b0\u1eddi s\u1ed1ng s\u00f3t l\u00e2u d\u00e0i sau ung th\u01b0 ph\u1ee5 khoa...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

NOGGO S19 \u2013 BI\u1ec2U HI\u1ec6N VIII (8)<\/a><\/h3><\/header>
\n

NOGGO S19 \u2013 BI\u1ec2U HI\u1ec6N VIII (8) D\u00e0nh cho b\u1ec7nh nh\u00e2n m\u1eafc ung th\u01b0 bu\u1ed3ng tr\u1ee9ng giai \u0111o\u1ea1n nh\u1eb9 (Nh\u00f3m A) ho\u1eb7c u bu\u1ed3ng tr\u1ee9ng ranh gi\u1edbi (Nh\u00f3m B \u2013...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

BI\u1ec2U TH\u1ee8C VI (6)<\/a><\/h3><\/header>
\n

NOGGO S13 \/ ENGOT-ov40 \u2013 TH\u1ec2 HI\u1ec6N VI (6) CAROLIN G\u1eb6P HANNA D\u00e0nh cho b\u1ec7nh nh\u00e2n m\u1eafc ung th\u01b0 bu\u1ed3ng tr\u1ee9ng, \u1ed1ng d\u1eabn tr\u1ee9ng v\u00e0 ph\u00fac m\u1ea1c \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ea9n...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

ENGOT-ov83 \/ CATALINA-2<\/a><\/h3><\/header>
\n

ENGOT-ov83 \/ CATALINA-2 Nghi\u00ean c\u1ee9u \u0111i\u1ec1u tr\u1ecb nh\u1eb1m \u0111\u00e1nh gi\u00e1 hi\u1ec7u qu\u1ea3 v\u00e0 \u0111\u1ed9 an to\u00e0n c\u1ee7a thu\u1ed1c m\u1edbi TORL-1-23 \u1edf b\u1ec7nh nh\u00e2n ung th\u01b0 bu\u1ed3ng tr\u1ee9ng giai \u0111o\u1ea1n ti\u1ebfn...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

ENGOT-ov47-TR\/ NOGGO-TR2 \u2013 TR\u1ee2 GI\u00daP-ER<\/a><\/h3><\/header>
\n

ENGOT-ov47-TR\/ NOGGO-TR2 \u2013 TR\u1ee2 GI\u00daP-ER NGHI\u00caN C\u1ee8U QUAN S\u00c1T N\u1ed2NG \u0110\u1ed8 HE4 TRONG M\u00c1U \u1ede B\u1ec6NH NH\u00c2N N\u1eee M\u1eaeC UNG TH\u01af BU\u1ed2NG TR\u1ee8NG T\u00c1I PH\u00c1T L\u1ea6N \u0110\u1ea6U Nghi\u00ean c\u1ee9u HELP-ER...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

AGO-OVAR 2.46 \/ ENGOT-ov81 \/ RAMP 301<\/a><\/h3><\/header>
\n

AGO-OVAR 2.46 \/ ENGOT-ov81 \/ RAMP 301 NGHI\u00caN C\u1ee8U L\u00c2M S\u00c0NG V\u1ec0 UNG TH\u01af BU\u1ed2NG TR\u1ee8NG TH\u1ec2 THANH D\u1ea0NG H\u1ed6N H\u1ee2P T\u00c1I PH\u00c1T AGO-OVAR 2.46 \/ ENGOT-ov81 \/ RAMP 301...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

NOGGO ov54 – SCOUT-1<\/a><\/h3><\/header>
\n

NOGGO ov54 – Trinh s\u00e1t 1 Nghi\u00ean c\u1ee9u quan s\u00e1t nh\u1eb1m thu th\u1eadp d\u1eef li\u1ec7u t\u1eeb sinh ho\u1ea1t th\u01b0\u1eddng nh\u1eadt c\u1ee7a b\u1ec7nh nh\u00e2n ung th\u01b0 bu\u1ed3ng tr\u1ee9ng \u0111ang \u0111i\u1ec1u tr\u1ecb...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

N-PLUS<\/a><\/h3><\/header>
\n

NOGGO ov53\/ ENGOT-ov62 – N-Plus Nghi\u00ean c\u1ee9u \u0111\u1ea7u ti\u00ean tr\u00ean th\u1ebf gi\u1edbi nh\u1eb1m m\u1ee5c \u0111\u00edch gi\u1ea3m s\u1ed1 chu k\u1ef3 h\u00f3a tr\u1ecb v\u00e0 do \u0111\u00f3 r\u00fat ng\u1eafn th\u1eddi gian h\u00f3a tr\u1ecb...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

NI CAROLIN<\/a><\/h3><\/header>
\n

NIS Niraparib \u2013 NOGGO-ov45 \u2013 CAROLIN D\u00e0nh cho b\u1ec7nh nh\u00e2n ung th\u01b0 bu\u1ed3ng tr\u1ee9ng nh\u1ea1y c\u1ea3m v\u1edbi platin kh\u00f4ng c\u00f3 ch\u1ed1ng ch\u1ec9 \u0111\u1ecbnh v\u1edbi niraparib. Nghi\u00ean c\u1ee9u quan s\u00e1t kh\u00f4ng...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

NOGGO S15 \u2013 FraStROC<\/a><\/h3><\/header>
\n

NOGGO S15 \u2013 FraStROC Nghi\u00ean c\u1ee9u d\u00e0nh cho b\u1ec7nh nh\u00e2n m\u1eafc ung th\u01b0 bu\u1ed3ng tr\u1ee9ng t\u00e1i ph\u00e1t ho\u1eb7c t\u00e1i nhi\u1ec5m. NGHI\u00caN C\u1ee8U TR\u00caN B\u1ec6NH NH\u00c2N N\u1eee M\u1eaeC UNG TH\u01af BU\u1ed2NG...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

AGO-OVAR 28 \/ ENGOT-OV57<\/a><\/h3><\/header>
\n

AGO-OVAR 28 \/ ENGOT-ov57 M\u1ed9t th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng giai \u0111o\u1ea1n III ng\u1eabu nhi\u00ean, nh\u00e3n m\u1edf \u0111\u1ec3 \u0111\u00e1nh gi\u00e1 niraparib \u0111\u01a1n \u0111\u1ed9c so v\u1edbi s\u1ef1 k\u1ebft h\u1ee3p c\u1ee7a niraparib v\u00e0...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n

BI\u1ec2U TH\u1ee8C XX (20)<\/a><\/h3><\/header>
\n

NOGGO S33\/ Bi\u1ec3u th\u1ee9c XX (20) KH\u1ea2O S\u00c1T B\u1ec6NH NH\u00c2N N\u1eee M\u1eaeC B\u1ec6NH U PH\u1ee4 KHOA V\u1ec0 VI\u1ec6C TRUY\u1ec0N \u0110\u1ea0T TIN X\u1ea4U Vi\u1ec7c th\u00f4ng b\u00e1o tin x\u1ea5u l\u00e0 m\u1ed9t ph\u1ea7n...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n
<\/i><\/a><\/div>
\n \"\"\n <\/div>\n <\/div>

D\u1eef li\u1ec7u nghi\u00ean c\u1ee9u m\u1edbi t\u1eeb ESMO 2025 – Li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch mang l\u1ea1i l\u1ee3i \u00edch s\u1ed1ng c\u00f2n \u0111\u1ea7u ti\u00ean cho b\u1ec7nh ung th\u01b0 bu\u1ed3ng tr\u1ee9ng kh\u00e1ng platinum.<\/a><\/h3><\/header>
\n

D\u1eef li\u1ec7u nghi\u00ean c\u1ee9u m\u1edbi t\u1eeb ESMO 2025 Li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch l\u1ea7n \u0111\u1ea7u ti\u00ean mang l\u1ea1i l\u1ee3i \u00edch gi\u00fap b\u1ec7nh nh\u00e2n s\u1ed1ng s\u00f3t. ung th\u01b0 bu\u1ed3ng tr\u1ee9ng kh\u00e1ng platinum...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article>

\n
\n
<\/i><\/a><\/div>
\n \"\"\n <\/div>\n <\/div>

Nh\u1eefng ph\u00e1t hi\u1ec7n quan tr\u1ecdng nh\u1ea5t c\u1ee7a ASCO v\u1ec1 ung th\u01b0 bu\u1ed3ng tr\u1ee9ng<\/a><\/h3><\/header>
\n

Nh\u1eefng k\u1ebft qu\u1ea3 quan tr\u1ecdng nh\u1ea5t c\u1ee7a ASCO n\u0103m 2025 trong ung th\u01b0 bu\u1ed3ng tr\u1ee9ng H\u00f4m qua, h\u1ed9i ngh\u1ecb c\u1eadp nh\u1eadt l\u1ea7n th\u1ee9 26 c\u1ee7a NOGGO v\u1ec1 ung th\u01b0 ph\u1ee5...<\/p>\u0110\u1ecdc th\u00eam<\/a><\/div>\n <\/div><\/div><\/div>\n <\/div>\n <\/article><\/div>\n

<\/div>\n <\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Tin t\u1ee9c Tin t\u1ee9c t\u1eeb khoa h\u1ecdc v\u00e0 th\u1ef1c ti\u1ec5n Studienziel erreicht! \u2013 Ergebnisse der ROSELLA-Studie Neue Erkenntnisse zur Behandlung von platinresistentem Eierstockkrebs \u2013 Ergebnisse der ROSELLA-Studie Ende Januar ver\u00f6ffentlichte der Pharmakonzern Corcept Therapeutics eine Pressemitteilung zu den positiven Studienergebnissen der ROSELLA Studie! Diese Studie hat… \u0110\u1ecdc th\u00eam Neuigkeiten f\u00fcr Patientinnen mit platinresistentem Eierstockkrebs Neuigkeiten […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2190","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/pages\/2190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/comments?post=2190"}],"version-history":[{"count":1,"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/pages\/2190\/revisions"}],"predecessor-version":[{"id":2193,"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/pages\/2190\/revisions\/2193"}],"wp:attachment":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/vi\/wp-json\/wp\/v2\/media?parent=2190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}